Amyloid β, a risk factor for AD pathogenesis, could promote the activation of the NLRP3 inflammasome pathway in microglia [15], and NLRP3 deficiency clearly attenuates AD phenotypes, including the loss of spatial memory, in aged APP/PS1 mice [17]. The gene discussed is APP; the disease is Alzheimer disease.